Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 1
1986 1
1987 3
1988 5
1989 1
1990 4
1991 3
1993 2
1994 2
1995 2
1996 1
1997 3
1998 1
1999 4
2000 1
2001 1
2002 2
2003 1
2007 1
2008 1
2010 1
2011 2
2012 1
2014 1
2016 2
2017 3
2018 2
2019 2
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
AR101 Oral Immunotherapy for Peanut Allergy.
PALISADE Group of Clinical Investigators, Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC Jr, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW. PALISADE Group of Clinical Investigators, et al. Among authors: adelman dc. N Engl J Med. 2018 Nov 22;379(21):1991-2001. doi: 10.1056/NEJMoa1812856. Epub 2018 Nov 18. N Engl J Med. 2018. PMID: 30449234 Clinical Trial.
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J, Beyer K, Abbas A, Fernández-Rivas M, Turner PJ, Blumchen K, Nilsson C, Ibáñez MD, Deschildre A, Muraro A, Sharma V, Erlewyn-Lajeunesse M, Zubeldia JM, De Blay F, Sauvage CD, Byrne A, Chapman J, Boralevi F, DunnGalvin A, O'Neill C, Norval D, Vereda A, Skeel B, Adelman DC, du Toit G. O'B Hourihane J, et al. Among authors: adelman dc. Lancet Child Adolesc Health. 2020 Oct;4(10):728-739. doi: 10.1016/S2352-4642(20)30234-0. Epub 2020 Jul 20. Lancet Child Adolesc Health. 2020. PMID: 32702315 Clinical Trial.
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Vickery BP, Vereda A, Nilsson C, du Toit G, Shreffler WG, Burks AW, Jones SM, Fernández-Rivas M, Blümchen K, O'B Hourihane J, Beyer K, Smith A, Ryan R, Adelman DC. Vickery BP, et al. Among authors: adelman dc. J Allergy Clin Immunol Pract. 2021 May;9(5):1879-1889.e14. doi: 10.1016/j.jaip.2020.12.029. Epub 2020 Dec 24. J Allergy Clin Immunol Pract. 2021. PMID: 33359589 Free article. Clinical Trial.
Neuroimmunology.
Goetzl EJ, Adelman DC, Sreedharan SP. Goetzl EJ, et al. Among authors: adelman dc. Adv Immunol. 1990;48:161-90. doi: 10.1016/s0065-2776(08)60754-3. Adv Immunol. 1990. PMID: 1971989 Review. No abstract available.
Oral Immunotherapy for Peanut Allergy.
Vickery BP, Hourihane JO, Adelman DC. Vickery BP, et al. Among authors: adelman dc. N Engl J Med. 2019 Feb 14;380(7):691-692. doi: 10.1056/NEJMc1817331. N Engl J Med. 2019. PMID: 30763186 No abstract available.
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page